SCREEN IFA TEST COVID+INFLUENZA

Covid-19 Antigen + Influenza Combo Rapid Test

Product Code: FI-CIC-525

Register or Login to see the price
This item is selling fast!
  • Request a quotation for shipping costs or use your trusted courier
  • Money back guarantee
  • Products not in stock can be ordered with delivery in 2/3 weeks

Covid-19 Antigen + Influenza Combo Rapid Test – Product code: FI-CIC-525

A Fluorescence Immunoassay test for qualitative detection of SARS-CoV-2 Nucleocapsid protein antigens, Influenza A and Influenza B virus in human nasopharynx with the use of SCREEN IFA ANALYZER. The COVID-19 Antigen/Influenza A+B Combo Test Cassette (Nasopharyngeal Swab) is intended for in vitro detection of SARS-CoV-2 Nucleocapsid protein, influenza A and B virus in nasopharyngeal swab specimens. It is intended to aid in the differential diagnosis of SARS-CoV-2, influenza A and B viral infections. The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases. Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract. It is a communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus.1 Influenza outbreaks occur each year during the fall and winter months. Type A viruses are typically more prevalent than type B viruses and are associated with most serious influenza epidemics, while type B infections are usually milder. The gold standard of laboratory diagnosis is 14-day cell culture with one of a variety of cell lines that can support the growth of influenza virus.2 Cell culture has limited clinical utility, as results are obtained too late in the clinical course for effective patient intervention. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a newer method that is generally more sensitive than culture with improved detection rates over culture of 2-23% ³. However, RT-PCR is expensive, complex and must be performed in specialized laboratories.

For professional in vitro diagnostic use only.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.